Analyst Reco. ZimVie Inc.

Equities

ZIMV

US98888T1079

Market Closed - Nasdaq Other stock markets 21:00:00 13/05/2024 BST			5-day change	1st Jan Change
16.82 ^USD	+1.02%		+6.32%	-5.24%

05-08	Transcript : ZimVie Inc., Q1 2024 Earnings Call, May 08, 2024
05-08	Earnings Flash (ZIMV) ZIMVIE Reports Q1 EPS $0.08	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Barclays Adjusts Price Target on ZimVie to $16 From $13, Maintains Underweight Rating	03-05	MT
Needham Starts ZimVie With Hold Rating	11-16	MT
Barclays Adjusts Price Target on ZimVie to $11 From $7, Keeps Underweight Rating	08/08/23	MT
Barclays Adjusts Price Target on ZimVie to $7 From $5, Keeps Underweight Rating	09/05/23	MT
Traders Digest Latest Fed Rate Increase, Economic Data, Driving Narrow Premarket Losses for US Equity Futures	04/05/23	MT
ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®	03/04/23	GL
ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®	03/04/23	AQ
ZimVie Inc. Announces Expand Reimbursement and Exemplary Clinical Rating for Mobi-C(R)	03/04/23	CI
Barclays Adjusts ZimVie Price Target to $5 From $9, Maintains Underweight Rating	06/03/23	MT
Barclays Initiates Coverage on ZimVie With Underweight Rating, $9 Price Target	21/12/22	MT
JPMorgan Initiates ZimVie at Neutral, Sets Price Target at $20	17/06/22	MT
JPMorgan Starts ZimVie at Neutral With $20 Price Target	17/06/22	MT
Guggenheim Initiates ZimVie at Neutral	18/03/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer